Literature DB >> 10814960

Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.

B H Koffman1, A S Kennedy, M Heyman, J Colonna, C Howell.   

Abstract

Posttransplant lymphoproliferative disorder (PTLD) is a common and life-threatening complication of immunosuppression used to prevent rejection of solid organ and bone marrow transplants. There is no standardized treatment algorithm, but numerous management strategies are available. We describe a patient who developed a solitary lymphoproliferative lesion in the porta hepatis 9 months after orthotopic liver transplant. Following reduction in immunosuppression with no response, she was treated with involved field radiotherapy utilizing CT-based treatment planning. A partial radiographic response was obtained, and she has not developed disease in the engrafted liver or systemically. Based on the present case report, involved field radiotherapy seems to be a reasonable treatment option for patients with localized PTLD. Int. J. Cancer (Radiat. Oncol. Invest.) 90:104-109, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814960     DOI: 10.1002/(sici)1097-0215(20000420)90:2<104::aid-ijc6>3.0.co;2-0

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Posttransplant lymphoproliferative disease in liver transplant patients.

Authors:  Christina Hartmann; Marcus Schuchmann; Tim Zimmermann
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

Review 2.  EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target.

Authors:  Keri Toner; Catherine M Bollard
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

Review 3.  Post-transplant lymphoproliferative disorder in the pelvis successfully treated with consolidative radiotherapy.

Authors:  Omar Habibeh; Khaled Elsayad; Jan Kriz; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2016-06-22       Impact factor: 3.621

Review 4.  The management of posttransplant lymphoproliferative disorder.

Authors:  Noelle V Frey; Donald E Tsai
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

5.  A 5-year old male with "leukemic form" of disseminated post-transplant lymphoproliferative disorder.

Authors:  Saadiya A Haque; Bhaskar Kallakury; Aziza Shad; Kristen Snyder
Journal:  Pediatr Rep       Date:  2010-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.